- Home
- PTLO vs ETON Comparison
PTLO vs ETON Comparison
Compare PTLO & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PTLO | ETON |
|---|---|---|
| Founded | 1963 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Restaurants | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 433.0M | 411.9M |
| IPO Year | 2021 | 2018 |
Fundamental Metrics
Financial Performance| Metric | PTLO | ETON |
|---|---|---|
| Price | $5.51 | $17.28 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 9 | 3 |
| Target Price | $8.06 | ★ $29.67 |
| AVG Volume (30 Days) | ★ 1.5M | 275.6K |
| Earning Date | 05-28-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.27 | N/A |
| Revenue | ★ $732,066,000.00 | $39,011,000.00 |
| Revenue This Year | $9.71 | $107.23 |
| Revenue Next Year | $6.20 | $29.72 |
| P/E Ratio | $19.56 | ★ N/A |
| Revenue Growth | 3.03 | ★ 23.29 |
| 52 Week Low | $4.41 | $11.09 |
| 52 Week High | $14.47 | $23.00 |
Technical Indicators
Market Signals| Indicator | PTLO | ETON |
|---|---|---|
| Relative Strength Index (RSI) | 48.70 | 57.51 |
| Support Level | $5.34 | $15.93 |
| Resistance Level | $6.12 | $17.59 |
| Average True Range (ATR) | 0.33 | 0.98 |
| MACD | -0.06 | 0.18 |
| Stochastic Oscillator | 36.27 | 50.55 |
Price Performance
Historical ComparisonAbout PTLO Portillo's Inc.
Portillos Inc serves the Chicago street food industry through high-energy and multichannel restaurants designed to ignite the senses and create memorable dining experiences. It owns and operates fast-casual restaurants in the United States, along with two food production commissaries in Illinois. Its menu includes hot dogs, beef and sausage sandwiches, sandwiches and ribs, salads, burgers, chicken, Barnelli's pasta, sides and soup, and desserts and shakes.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.